Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X

SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

(2013) Eric Letouzé et al.   CANCER CELL

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

(2013) Iñaki Comino-Méndez et al.   HUMAN MOLECULAR GENETICS

Mosaicism inHIF2A-Related Polycythemia-Paraganglioma Syndrome

(2013) Alexandre Buffet et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction

(2013) I. Jochmanova et al.   JNCI-Journal of the National Cancer Institute

Double stable isotope ultra performance liquid chromatographic-tandem mass spectrometric quantification of tissue content and activity of phenylethanolamine N-methyltransferase, the crucial enzyme responsible for synthesis of epinephrine

(2012) Nan Qin et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success

(2012) Cristina Branco-Price et al.   CANCER CELL

Metabolic reprogramming and two-compartment tumor metabolism

(2012) Barbara Chiavarina et al.   CELL CYCLE

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

(2012) N. Burnichon et al.   CLINICAL CANCER RESEARCH

DUSP6 is a novel transcriptional target of p53 and regulates p53-mediated apoptosis by modulating expression levels of Bcl-2 family proteins

(2012) Sujan Piya et al.   FEBS LETTERS

Functional analysis of GNG2 in human malignant melanoma cells

(2012) Ichiro Yajima et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia

(2012) Zhengping Zhuang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin

(2011) Manjula Mahata et al.   CELL AND TISSUE RESEARCH

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

(2011) Graeme Eisenhofer et al.   EUROPEAN JOURNAL OF CANCER

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

(2011) Nelly Burnichon et al.   HUMAN MOLECULAR GENETICS

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

(2011) Iñaki Comino-Méndez et al.   NATURE GENETICS

Opposing roles for HIF-1  and HIF-2  in the regulation of angiogenesis by mononuclear phagocytes

(2010) T. D. Eubank et al.   BLOOD

Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas

(2010) Elena López-Jiménez et al.   MOLECULAR ENDOCRINOLOGY

Hypoxic stress-induced changes in adrenergic function: role � of HIF1α

(2009) T. C. Tai et al.   JOURNAL OF NEUROCHEMISTRY

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One

HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma

(2008) John D. Gordan et al.   CANCER CELL

HIF-1α and HIF-2α have divergent roles in colon cancer

(2008) Takaaki Imamura et al.   INTERNATIONAL JOURNAL OF CANCER

The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage

(2008) Haiyang Li et al.   JOURNAL OF CELL BIOLOGY